Evidence map›Paper›PMID 28698779›Full record

ArticleMediterranean journal of hematology and infectious diseases2017

Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience.

Michele Malagola, Bendetta Rambaldi, Giuseppe Ravizzola, Chiara Cattaneo, Erika Borlenghi, Nicola Polverelli, Alessandro Turra, Enrico Morello, Cristina Skert, Valeria Cancelli and 11 more

Open access · goldAbstract read
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 1 institution in 1 country.

Michele MalagolaChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Bendetta RambaldiChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Giuseppe RavizzolaInstitute of Microbiology, Department of Molecular and Transplational Medicine, University of Brescia, Italy.
Chiara CattaneoDivision of Hematology, ASST-Spedali Civili, Brescia, Italy.
Erika BorlenghiDivision of Hematology, ASST-Spedali Civili, Brescia, Italy.
Nicola PolverelliChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Alessandro TurraChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Enrico MorelloChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Cristina SkertChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Valeria CancelliChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Federica CattinaChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Giorgio GiannettaChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Simona BernardiChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Simone PeruccaChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
Camillo AlmiciLaboratory for Stem Cells Manipulation and Cryopreservation, ASST-Spedali Civili, Brescia, Italy.
Aldo RoccaroASST-Spedali Civili, Coordinamento e Progettazione Ricerca Clinica, CREA Laboratory, Brescia, Italy.
Liana SignoriniChair of Infectious Diseases, Division of Infectious and Tropical Diseases, University of Brescia, Italy.
Roberto StelliniChair of Infectious Diseases, Division of Infectious and Tropical Diseases, University of Brescia, Italy.
Francesco CastelliChair of Infectious Diseases, Division of Infectious and Tropical Diseases, University of Brescia, Italy.
Arnaldo CarusoInstitute of Microbiology, Department of Molecular and Transplational Medicine, University of Brescia, Italy.
Domenico RussoChair of Hematology, Clinical and Experimental Sciences Department, University of Brescia, Bone Marrow Transplant Unit, ASST-Spedali Civili, Brescia, Italy, Italy.
University of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBlood stream infections (BSIs) represent a major complication of allo-SCT and are a major cause of morbidity and mortality during and after bone marrow aplasia.

objectivesThe objective of this study was to describe the incidence and outcome of BSIs in a cohort of patients submitted to allo-SCT, in order to track changes of the epidemiology and bacteria resistance.

methodsWe retrospectively analyzed the microbiological data of 162 patients allotransplanted in Brescia University Hospital, over a period of 6 years.

resultsEighty patients experienced a BSIs for a total of 119 isolates. In 77 cases (65%) a Gram positive bacteria was isolated, being coagulase negative

conclusionsThese data confirm that BSIs, mainly sustained by Gram positive bacteria, are frequent in allotransplanted patients (50% of the cases) and may influence the outcome of allotransplanted patients, being antibiotics resistance highly frequent among these bacteria.

Indexed as

Antimicrobical ResistanceBacterial InfectionsBone Marrow Transplantation

Identifiers

PMID28698779
PMCPMC5499498
OpenAlexW2627773855

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.